CBD Life Sciences Inc. (CBDL)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
At close: Sep 4, 2026
CBD Life Sciences Market Cap
CBD Life Sciences has a market cap or net worth of $1.19 million as of September 4, 2026. Its market cap has increased by 37.29% in one year.
Market Cap
1.19M
Enterprise Value
920.88K
Revenue
98.32K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
ChartMarket Cap Chart
Since May 31, 2012, CBD Life Sciences's market cap has decreased from 36.67M to 1.19M, a decrease of -96.76%. That is a compound annual growth rate of -21.37%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 1.19M | 4.12% |
| Dec 31, 2025 | 1.14M | -24.91% |
| Dec 31, 2024 | 1.52M | 3,469.86% |
| Dec 29, 2023 | 42.51K | 4.42% |
| Dec 30, 2022 | 40.71K | -99.50% |
| Dec 31, 2021 | 8.14M | 62.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CannaPharmaRX | 1.61M |
| Medical Marijuana | 1.39M |
| Maple Leaf Green World | 1.37M |
| Dakshidin Corporation | 1.33M |
| Herborium Group | 1.14M |
| Nascent Pharma Holdings | 1.06M |
| Software Effective Solutions | 1.03M |
| Aion Therapeutic | 994.30K |